A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

PURPOSE: This study was designed to establish the maximum tolerated dose (MTD) and to evaluate tolerability, pharmacokinetics, and antitumor activity of etirinotecan pegol. EXPERIMENTAL DESIGN: Patients with refractory solid malignancies were enrolled and assigned to escalating-dose cohorts. Patient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jameson, Gayle S., Hamm, John T., Weiss, Glen J., Alemany, Carlos, Anthony, Stephen, Basche, Michele, Ramanathan, Ramesh K., Borad, Mitesh J., Tibes, Raoul, Cohn, Allen, Hinshaw, Ioana, Jotte, Robert, Rosen, Lee S., Hoch, Ute, Eldon, Michael A., Medve, Robert, Schroeder, Katrina, White, Erica, Von Hoff, Daniel D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4104496/
https://ncbi.nlm.nih.gov/pubmed/23136196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1201
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller